SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013274
Filing Date
2022-08-11
Accepted
2022-08-11 16:07:48
Documents
72
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lqda-20220630x10q.htm   iXBRL 10-Q 1738327
2 EX-31.1 lqda-20220630xex31d1.htm EX-31.1 15300
3 EX-31.2 lqda-20220630xex31d2.htm EX-31.2 15301
4 EX-32.1 lqda-20220630xex32d1.htm EX-32.1 7561
5 EX-32.2 lqda-20220630xex32d2.htm EX-32.2 7540
6 GRAPHIC lqda-20220630x10q001.jpg GRAPHIC 631
7 GRAPHIC lqda-20220630x10q002.jpg GRAPHIC 655
  Complete submission text file 0001558370-22-013274.txt   7377735

Data Files

Seq Description Document Type Size
8 EX-101.SCH lqda-20220630.xsd EX-101.SCH 51768
9 EX-101.CAL lqda-20220630_cal.xml EX-101.CAL 46328
10 EX-101.DEF lqda-20220630_def.xml EX-101.DEF 208397
11 EX-101.LAB lqda-20220630_lab.xml EX-101.LAB 458620
12 EX-101.PRE lqda-20220630_pre.xml EX-101.PRE 363682
66 EXTRACTED XBRL INSTANCE DOCUMENT lqda-20220630x10q_htm.xml XML 1282281
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

IRS No.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39724 | Film No.: 221155742
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences